# A Drug Interaction Study of LY3154207 in Healthy Participants

> **NCT03942029** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3154207 Capsule
- **DRUG:** LY3154207 Tablet
- **DRUG:** Placebo
- **DRUG:** Fluconazole Tablet

## Key facts

- **NCT ID:** NCT03942029
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-21
- **Primary completion:** 2019-12-28
- **Final completion:** 2019-12-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03942029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03942029, "A Drug Interaction Study of LY3154207 in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03942029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*